Monograph Title | Section | Source Publication | Page Number | Errata Post Date Sort ascending | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
CARBAMAZEPINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Carbamazepine Related Compound A RS: Change 238.28 to: 238.29 AND In USP Carbamazepine Related Compound B RS: Change 193.24 to: 193.25 AND In USP 9-Methylacridine RS: Change 193.24 to: 193.25 |
<565> BOTANICAL EXTRACTS | PREPARATIONS | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In General Pharmacopeial Requirements/Pesticide Residues: Change where L is the limit in the original article as listed in Table 4 (see Pesticide Residue Analysis under Articles of Botanical Origin <561>)… Read More |
DOXYCYCLINE HYCLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change 480.13 to: 480.90 |
RIFABUTIN | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 847.00 to: 847.02 AND Change (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,16,18,20-Tetrahydroxy-1′-isobutyl-14-methoxy-7,9,15,17,19,21,25-heptamethylspiro[9,4-(epoxypentadeca[1,11,13]… Read More |
DOXYCYCLINE HYCLATE | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 1025.87 to: 1025.88 |
FLUOCINOLONE ACETONIDE | Organic Impurities | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Acceptance criteria/Total impurities: Change NMT 2.5%. Disregard any peak below 0.05% of the peak area of fluocinolone acetonide from the Standard solution. to: NMT 2.5%. Disregard any peak below 0.05% of the peak area of… Read More |
NANDROLONE DECANOATE | ASSAY/Procedure | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change Calculate the percentage of Nandrolone Decanoate (C28H44O3) in the portion of Nandrolone Decanoate taken: to: Calculate the percentage of nandrolone decanoate (C28H44O… Read More |
IBUPROFEN ORAL SUSPENSION | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change Result = (RU/RS) x CS x V x (D/WU) x (1/L) x 100 RU = peak area ratio of ibuprofen to benzophenone from the … Read More |
MECAMYLAMINE HYDROCHLORIDE | USP Reference standards <11> | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In USP Mecamylamine Related Compound A RS: Change N,1,7,7-Tetramethyl bicyclo [2.2.1]heptan-2-amine. C11H21N 167.29 to: N,1,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride. C11… Read More |
MUPIROCIN CALCIUM | CHEMICAL INFORMATION | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | Change 1075.34 to: 1075.35 |
<621> CHROMATOGRAPHY | ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS | USPNF Online | Online | 29-Apr-2022 | 1-Dec-2022 | NA | NA | In Liquid Chromatography: Isocratic Elution/Injection volume: Change Result = (Vinj2 = Vinj1 (L2 dc22 )/(L1… Read More |
MUPIROCIN CREAM | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
BROMOCRIPTINE MESYLATE CAPSULES | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In Analysis: Change bromocriptine mesylate (C32H40BrN5O5 · CH4SO3) to: bromocriptine (C32H40BrN5O5) AND In… Read More |
DACARBAZINE FOR INJECTION | IDENTIFICATION | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | Delete Identification test C |
MUPIROCIN CALCIUM | IMPURITIES/Organic Impurities/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote b: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
MUPIROCIN NASAL OINTMENT | Related compounds/Table 1 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote 2: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
ACYCLOVIR | ASSAY/Procedure | USPNF Online | Online | 29-Apr-2022 | 1-May-2023 | NA | NA | In the Sample solution: Change 0.1 N sodium hydroxide to: 0.01 N sodium hydroxide |
DACARBAZINE FOR INJECTION | IMPURITIES | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | Delete Limit of 2-Azahypoxanthine test |
MUPIROCIN OINTMENT | IMPURITIES/Organic Impurities/Table 2 | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In footnote b: Change 9-{(E)-4-[(2R,3aS,6S,7S,8aRS)-2-{(1RS,2S,3S)-1,3-Dihydroxy-2-methylbutyl}-7-hydroxyhexahydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyloxy}nonanoic acid. to:… Read More |
ONDANSETRON TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Table 1/footnotes: Change b1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one. c1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one. d3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one. … Read More |
POWDERED VALERIAN EXTRACT | DEFINITION | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid, on the dried basis. to: calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid, on the anhydrous basis. |
PANTOPRAZOLE SODIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In USP Pantoprazole Related Compound E RS: Change A mixture of the stereoisomers of 6,6′-bis(difluoromethoxy)-2,2′-bis[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H,1′H-5,5′-bibenzimidazolyl. to: 6,6′-Bis(difluoromethoxy)-2,2′-bis[[(3,4-… Read More |
CORN STARCH | IMPURITIES/Limit of Sulfur Dioxide | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Bromophenol blue indicator solution: Change 0.2 mg/mL of bromophenol blue in dilute alcohol. Filter if necessary. to: Dissolve 100 mg of bromophenol blue in 100 mL of dilute alcohol (1 in 5), and filter if necessary. |
ONDANSETRON TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. to: USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H… Read More |
POWDERED VALERIAN EXTRACT | COMPOSITION/Content of Valerenic Acids | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Acceptance criteria: Change calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid on the dried basis to: calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid on the anhydrous… Read More |
ONDANSETRON ORAL SOLUTION | USP Reference standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change USP Ondansetron Related Compound A RS 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. USP Ondansetron Related Compound C RS 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one. USP… Read More |
ACYCLOVIR FOR INJECTION | IMPURITIES/Procedure | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Standard solution A: Change 0.5 μg/mL of Acyclovir standard solution in Solution A to: 0.5 μg/mL of USP Acyclovir RS from Acyclovir standard solution in Solution A AND In Standard solution B:… Read More |
<621> CHROMATOGRAPHY | SYSTEM SUITABILITY | USPNF Online | Online | 25-Mar-2022 | 1-Dec-2022 | NA | NA | Change System Repeatability—Assay of an Active Substance or an Excipient to: System Repeatability |
DIBASIC POTASSIUM PHOSPHATE | ASSAY/Procedure | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Analysis: Change Titrate the Blank with 1 N sodium hydroxide VS, and record the volume of 1 N sodium hydroxide VS consumed. Titrate the excess acid in the Sample solution with 1 N sodium hydroxide VS to the inflection point at pH 4, and… Read More |
MAGNESIUM OXIDE | IMPURITIES/Limit of Calcium | USPNF Online | Online | 25-Feb-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of Magnesium Hydroxide in the Sample solution (mg/mL) to: CU = concentration of Magnesium Oxide in the Sample solution (mg/mL) |
<659> PACKAGING AND STORAGE REQUIREMENTS | GENERAL DEFINITIONS/Packaging Definitions | Second Supplement to USP43–NF38 | Online | 26-Mar-2021 | 1-Dec-2025 | NA | NA | In Light-resistant container: Change 〈661.2〉, Functionality, Spectral Transmission Requirements for Light-Resistant Components and Systems. to: 〈661.2〉, Functionality Test Method, Spectral Transmission Requirements for Light-… Read More |